STONEPINE CAPITAL MANAGEMENT, LLC Holdings
STONEPINE CAPITAL MANAGEMENT, LLC is an investment fund managing more than 222.44M US dollars. The largest holdings include Amryt Pharma, QuidelOrtho and CTI BioPharma Corp.. In Q3 2022 the fund bought assets of total value of 43.37M US dollars and sold assets of total value of 32.86M US dollars.
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$222.44M
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-3.18%
quarter
STONEPINE CAPITAL MANAGEMENT, LLC 1 year portfolio value change:
-38.69%
1 year
STONEPINE CAPITAL MANAGEMENT, LLC 3 years portfolio value change:
-20.61%
3 years
STONEPINE CAPITAL MANAGEMENT, LLC 5 years portfolio value change:
+7.41%
5 years
STONEPINE CAPITAL MANAGEMENT, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 22233000 | 22035000 |
| Q2 2016 | 23045000 | 19969000 |
| Q3 2016 | 69175000 | 45603000 |
| Q4 2016 | 84472000 | 3188000 |
| Q1 2017 | 33890000 | 20550000 |
| Q2 2017 | 58980000 | 37298000 |
| Q3 2017 | 40572000 | 49453000 |
| Q4 2017 | 46158000 | 52529000 |
| Q1 2018 | 69159000 | 41358000 |
| Q2 2018 | 30658000 | 41621000 |
| Q3 2018 | 22289000 | 22487000 |
| Q4 2018 | 10037000 | 55807000 |
| Q1 2019 | 75357000 | 22076000 |
| Q2 2019 | 5180000 | 18846000 |
| Q3 2019 | 15274000 | 57827000 |
| Q4 2019 | 42868000 | 5065000 |
| Q1 2020 | 28294000 | 74355000 |
| Q2 2020 | 6096000 | 43017000 |
| Q3 2020 | 43745000 | 2065000 |
| Q4 2020 | 41364000 | 9447000 |
| Q1 2021 | 108164000 | 47988000 |
| Q2 2021 | 43265000 | 37165000 |
| Q3 2021 | 82582000 | 20719000 |
| Q4 2021 | 80966000 | 54435000 |
| Q1 2022 | 37575000 | 13440000 |
| Q2 2022 | 30917000 | 42743000 |
| Q3 2022 | 43373000 | 32862000 |
STONEPINE CAPITAL MANAGEMENT, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 19.37% Portfolio value: 43.09M Avg. open price: $12.57 Current price: $7.16 P/L: -43.03% Sold -1.12% shares Q3 2022 |
| Portfolio share: 16.12% Portfolio value: 35.85M Avg. open price: $97.18 Current price: $93.6 P/L: -3.68% Bought +318.77% shares Q3 2022 |
| Portfolio share: 14.83% Portfolio value: 32.99M Avg. open price: $3.17 Current price: $5.61 P/L: +77.05% Bought +54.01% shares Q3 2022 |
| Portfolio share: 9.07% Portfolio value: 20.16M Avg. open price: $2.34 Current price: $1.52 P/L: -35.04% Bought +11.00% shares Q3 2022 |
| Portfolio share: 7.02% Portfolio value: 15.60M Avg. open price: $4.62 Current price: $9.99 P/L: +116.34% Bought +31.02% shares Q3 2022 |
| Portfolio share: 5.46% Portfolio value: 12.15M Avg. open price: N/A Current price: $3.25 P/L: N/A Sold -28.57% shares Q3 2022 |
| Portfolio share: 4.21% Portfolio value: 9.35M Avg. open price: $8.7 Current price: $8.31 P/L: -4.50% Bought +1.19% shares Q3 2022 |
| Portfolio share: 4.19% Portfolio value: 9.31M Avg. open price: $4.53 Current price: $1.18 P/L: -74.08% Sold -3.45% shares Q3 2022 |
| Portfolio share: 3.85% Portfolio value: 8.57M Avg. open price: $112.51 Current price: $69.7 P/L: -38.05% Sold -0.68% shares Q3 2022 |
| Portfolio share: 3.66% Portfolio value: 8.14M Avg. open price: $3.38 Current price: $1.71 P/L: -49.41% Sold -0.96% shares Q3 2022 |
| Portfolio share: 3.29% Portfolio value: 7.32M Avg. open price: N/A Current price: $1.73 P/L: N/A Sold -23.56% shares Q3 2022 |
| Portfolio share: 1.83% Portfolio value: 4.07M Avg. open price: $3.76 Current price: $2.12 P/L: -43.79% Sold -37.02% shares Q3 2022 |
| Portfolio share: 1.54% Portfolio value: 3.42M Avg. open price: $12.51 Current price: $2.43 P/L: -80.58% Bought +0.40% shares Q3 2022 |
| Portfolio share: 1.49% Portfolio value: 3.30M Avg. open price: $1.22 Current price: $3.43 P/L: +182.16% Bought +0.13% shares Q2 2022 |
| Portfolio share: 1.27% Portfolio value: 2.83M Avg. open price: $3.65 Current price: $1.79 P/L: -50.99% Sold -55.83% shares Q3 2022 |
| Portfolio share: 0.81% Portfolio value: 1.80M Avg. open price: $8.45 Current price: $2.29 P/L: -72.90% Sold -0.10% shares Q3 2022 |
| Portfolio share: 0.74% Portfolio value: 1.63M Avg. open price: $16.64 Current price: $20.22 P/L: +21.49% N/A Q2 2022 |
| Portfolio share: 0.72% Portfolio value: 1.61M Avg. open price: $8.6 Current price: $6.98 P/L: -18.82% N/A Q3 2022 |
| Portfolio share: 0.52% Portfolio value: 1.15M Avg. open price: $26.91 Current price: $19.65 P/L: -26.99% Bought +40.40% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $28.11 Current price: $37.98 P/L: +35.11% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.35 Current price: $4.63 P/L: -50.48% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $2.5 Current price: $0.6 P/L: -76.01% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $24.41 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.05 Current price: $0.74 P/L: -75.74% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $9.1 Current price: $15.25 P/L: +67.58% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.18 Current price: $1.31 P/L: -74.69% Sold -100.00% shares Q3 2022 |
Showing TOP 26 STONEPINE CAPITAL MANAGEMENT's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of STONEPINE CAPITAL MANAGEMENT, LLC?
The biggest position of the STONEPINE CAPITAL MANAGEMENT, LLC is Amryt Pharma plc (AMYT) with 19.37% portfolio share worth of 43.1M US dollars.
Top 5 STONEPINE CAPITAL MANAGEMENT's holdings represent 66.41% of the portfolio:
- Amryt Pharma plc (AMYT) – 19.37%
- QuidelOrtho Corporation (QDEL) – 16.12%
- CTI BioPharma Corp. (CTIC) – 14.83%
- Xeris Biopharma Holdings, Inc. (XERS) – 9.07%
- Apollo Endosurgery, Inc. (APEN) – 7.02%
Who is the portfolio manager of STONEPINE CAPITAL MANAGEMENT, LLC?
The portfolio manager of the STONEPINE CAPITAL MANAGEMENT, LLC is .
What is the total asset value of the STONEPINE CAPITAL MANAGEMENT, LLC portfolio?
STONEPINE CAPITAL MANAGEMENT, LLC total asset value (portfolio value) is 222.44M US dollars.
Who is ?
is the portfolio manager of the STONEPINE CAPITAL MANAGEMENT, LLC.
What is (STONEPINE CAPITAL MANAGEMENT, LLC) fund performance?
STONEPINE CAPITAL MANAGEMENT's quarterly performance is -3.18%, annualy -38.69%. In the past 3 years, the value of 's portfolio has decreased by -21%. In the past 5 years, the value of the portfolio has increased by +7%.
What is the STONEPINE CAPITAL MANAGEMENT, LLC CIK?
STONEPINE CAPITAL MANAGEMENT's Central Index Key is 0001440771 .